液體療法市場規模、佔有率和成長分析：按產品、適應症、療法、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球靜脈輸液治療市場價值為 474.3 億美元，預計到 2025 年將成長至 506.1 億美元，到 2033 年將成長至 850.2 億美元，在預測期（2026-2033 年）內複合年成長率為 6.7%。

受人口老化和慢性病發病率上升的推動，全球靜脈輸液治療市場正經歷顯著成長。靜脈輸液治療可將藥物直接輸送到血液中，其高效性不僅能改善治療效果，還能根據患者的個別需求進行精準給藥。靜脈輸液治療的應用範圍廣泛，涵蓋抗生素、化療、營養支持等，為多種疾病提供了靈活的治療選擇。居家醫療需求的不斷成長以及靜脈輸液技術的進步進一步推動了市場擴張。然而，感染風險、導管使用相關併發症以及相關成本等挑戰仍需解決。總體而言，在不斷變化的患者護理偏好和對有效醫療解決方案的持續需求的驅動下，預計該市場將繼續成長。

全球靜脈輸液治療市場的成長要素

癌症、糖尿病和心血管疾病等慢性病的日益流行，顯著推動了對輸液治療產品和服務的需求。隨著這些健康問題的日益普遍，對輸液治療等有效治療方法的需求也隨之成長。這種需求的激增反映了醫療管理領域更廣泛的趨勢，即更加重視複雜疾病的管理，而創新的輸液治療方法在將藥物和營養物質直接輸送給患者方面發揮著至關重要的作用。因此，醫療機構擴大採用靜脈輸液療法來改善患者的治療效果，而對慢性病管理先進解決方案的需求，也正在推動全球靜脈輸液治療市場的成長。

全球靜脈輸液治療市場的限制因素

全球輸液治療市場面臨的一大挑戰是輸液治療產品和服務的高成本。在醫療資源往往有限的開發中國家，此經濟障礙尤其突出。因此，高昂的成本會限制先進輸液療法的普及和應用，阻礙市場成長。這些地區醫療基礎設施和經濟資源的不平衡進一步加劇了這個問題，導致很大一部分人口無法獲得所需的治療。解決這些與成本相關的障礙對於提高全球輸液治療的可近性和有效性至關重要。

全球靜脈輸液治療市場趨勢

全球靜脈輸液治療市場正經歷著向居家輸液治療的顯著轉變，這主要得益於人們對居家醫療解決方案日益成長的偏好。患者越來越傾向於在熟悉的環境中接受靜脈輸液治療，而非前往傳統的臨床場所，因為這樣更方便、更舒適、更經濟。科技的進步使得居家治療更加安全高效，進一步推動了這一趨勢。醫療服務提供者和保險公司也意識到了這些優勢，因此增加了對創新攜帶式輸液治療設備的投入和研發。預計居家輸液治療服務的需求將有助於提高患者的治療順從性，並改善整體健康。

目錄

介紹

• 調查目的
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二級資料和一級資料的方法
• 市場規模估算
• 市場假設與局限性

執行摘要

• 全球市場展望
• 供需趨勢分析
• 基於細分市場的機會分析

市場動態及展望

• 市場規模
• 市場動態
  • 促進者和機會
  • 抑制因素和挑戰
• 波特分析

關鍵市場分析

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 2025年市場魅力指數
• PESTLE分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

全球靜脈輸液治療市場規模：依產品分類

• 點滴幫浦
  • 攜帶式輸液泵
  • 固定式輸液泵
  • 注射器式輸液泵
  • 一次性泵浦
  • 大容量泵
  • 彈性體泵
• 點滴器
• 配件

全球靜脈輸液治療市場規模：依適應症分類

• 癌症
• 消化系統疾病與紊亂
• 鬱血性心臟衰竭
• 類風濕性關節炎
• 血友病
• 免疫力缺乏
• 其他

全球靜脈輸液治療市場規模：依治療類型分類

• 抗生素和抗病毒藥物
• 抗凝血治療
• 止吐藥
• 血液成分刺激因子
• 化療
• 營養療法
• 水合作用
• 疼痛管理

全球靜脈輸液治療市場規模：依應用領域分類

• 化療
• 糖尿病
• 消化系統疾病
• 疼痛管理
• 其他

全球靜脈輸液治療市場規模：依最終用戶分類

• 醫院
• 門診手術中心
• 診所
• 居家醫療環境

全球靜脈輸液治療市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Option Care Health Inc.（United States）
• Baxter International Inc.（United States）
• ICU Medical, Inc.（United States）
• B. Braun Melsungen AG（Germany）
• Terumo Corporation（Japan）
• Moog Inc.（United States）
• Fresenius SE & Co. KGaA（Germany）
• Smiths Medical（United Kingdom）
• JMS Co. Ltd.（Japan）
• Caesarea Medical Electronics（Israel）
• CareFusion Corporation（United States）
• Poly Medicure Limited（India）
• Nipro Corporation（Japan）
• Medtronic plc（Ireland）
• Becton, Dickinson and Company（BD）（United States）
• 3M Company（United States）
• Teleflex Incorporated（United States）
• Edwards Lifesciences Corporation（United States）
• Coloplast A/S（Denmark）
• Convatec Group plc（United Kingdom）

結論與建議

Global Infusion Therapy Market size was valued at USD 47.43 Billion in 2024 and is poised to grow from USD 50.61 Billion in 2025 to USD 85.02 Billion by 2033, growing at a CAGR of 6.7% during the forecast period (2026-2033).

The global infusion therapy market is experiencing notable growth, propelled by an aging population and the rising incidence of chronic diseases. Infusion therapy's efficiency in delivering medications directly into the bloodstream enhances treatment outcomes while allowing for precise dosing tailored to individual patient needs. With a diverse range of applications-from antibiotics and chemotherapy to nutritional support-it offers flexibility in treatment options across various medical conditions. The demand for home healthcare and advancements in infusion technology further fuel market expansion. However, challenges such as infection risks, complications from catheter use, and associated costs need to be addressed. Overall, the market is poised for continued growth, driven by the ongoing need for effective healthcare solutions amidst evolving patient care preferences.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infusion Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Infusion Therapy Market Segments Analysis

Global Infusion Therapy Market is segmented by Product, Indication, Therapy, Application, End-user and region. Based on Product, the market is segmented into Infusion Pumps, Infusion Set and Accessories. Based on Indication, the market is segmented into Cancer, Gastrointestinal Diseases/Disorders, Congestive Heart Failure, Rheumatoid Arthritis, Hemophilia, Immune Deficiencies and Others. Based on Therapy, the market is segmented into Antibiotic/Antiviral, Anti-coagulation, Anti-emetics, Blood Component Stimulating Factor, Chemotherapy, Nutrition, Hydration and Pain Management. Based on Application, the market is segmented into Chemotherapy, Diabetes, Gastrointestinal Diseases, Pain management and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Infusion Therapy Market

The rising incidence of chronic conditions, including cancer, diabetes, and cardiovascular diseases, is significantly driving the demand for infusion therapy products and services. As these health issues become more widespread, the need for effective treatment options like infusion therapy has intensified. This surge in demand reflects a broader trend towards managing complex medical conditions, where innovative infusion methods play a crucial role in delivering medications and nutrients directly to patients. Consequently, healthcare providers are increasingly adopting infusion therapy to enhance patient outcomes, thereby fueling growth in the global infusion therapy market as they seek advanced solutions for chronic disease management.

Restraints in the Global Infusion Therapy Market

A significant challenge facing the global infusion therapy market is the elevated costs linked to infusion therapy products and services. This financial barrier is particularly pronounced in developing nations, where healthcare access is often constrained. Consequently, the high expenses can limit the adoption and utilization of advanced infusion therapies, hindering market growth. The disparity in healthcare infrastructure and economic resources in these regions further exacerbates the issue, preventing a broad segment of the population from accessing necessary treatments. Addressing these cost-related obstacles will be crucial for enhancing the availability and effectiveness of infusion therapies worldwide.

Market Trends of the Global Infusion Therapy Market

The Global Infusion Therapy market is experiencing a significant shift towards home infusion therapy, driven by a rising preference for home-based healthcare solutions. Patients increasingly seek the convenience, comfort, and cost-effectiveness of receiving intravenous treatments in familiar surroundings rather than traditional clinical environments. This trend is further propelled by advancements in technology, enabling safer and more efficient home administration of therapies. Healthcare providers and payers are also recognizing the benefits, leading to increased investments and the development of innovative portable infusion devices. As a result, the demand for home infusion services is expected to enhance patient adherence and overall health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Infusion Therapy Market Size by Product & CAGR (2026-2033)

• Market Overview
• Infusion Pumps
  • Ambulatory Infusion Pumps
  • Stationary Infusion Pumps
  • Syringe Infusion Pumps
  • Disposable Pumps
  • Large Volume Pumps
  • Elastomeric pumps
• Infusion Set
• Accessories

Global Infusion Therapy Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Cancer
• Gastrointestinal Diseases/Disorders
• Congestive Heart Failure
• Rheumatoid Arthritis
• Hemophilia
• Immune Deficiencies
• Others

Global Infusion Therapy Market Size by Therapy & CAGR (2026-2033)

• Market Overview
• Antibiotic/Antiviral
• Anti-coagulation
• Anti-emetics
• Blood Component Stimulating Factor
• Chemotherapy
• Nutrition
• Hydration
• Pain Management

Global Infusion Therapy Market Size by Application & CAGR (2026-2033)

• Market Overview
• Chemotherapy
• Diabetes
• Gastrointestinal Diseases
• Pain management
• Others

Global Infusion Therapy Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Homecare Settings

Global Infusion Therapy Market Size & CAGR (2026-2033)

• North America (Product, Indication, Therapy, Application, End-user)
  • US
  • Canada
• Europe (Product, Indication, Therapy, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, Therapy, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, Therapy, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, Therapy, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Option Care Health Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moog Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JMS Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caesarea Medical Electronics (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareFusion Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poly Medicure Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Convatec Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations